• Japanese
  • Korean
  • Chinese
Cover Image

Global miRNA Market Outlook to 2018

The recent discovery of miRNA and its wide applicability have sparked off a lot of interest among researchers as well as commercial players. Owing to the same, there are numerous clinical trials being organized all over the world in order to assess the potential of miRNA in diverse fields such as Cancer, Asthma, Heart disorders, Diabetes, Hepatitis etc. The report, “Global miRNA Market Outlook to 2018” provides an in-depth analysis of the various aspects of miRNA at the industry as well as the research front.

The market has been divided into three sections i.e., The Americas, Europe and Asia Pacific. These regions have then been analyzed to draw patterns in terms of research areas and applicability. A brief look at the market suggests that cancer is the most researched topic and regions such as United States, United Kingdom, France, Israel and China are the major players interested in evaluating the role played by miRNA.

Most of the current research is focused on utilizing miRNA for diagnostic purposes such as expression profiling, response evaluation and setting potential biomarkers in diseases. Another application is in the field of therapeutics where miRNA mimics and inhibitors are being applied to control gene translation and consequently its expression.

After an exhaustive study of the industry, RNCOS has laid out the primary market players. These players are working over a vast variety of products such as miRNA extraction and purification kits, and miRNA mimics and inhibitors. There are other players who are solely providing miRNA associated diagnostic services and assessing their therapeutic potential.

Overall, even though the market is in its nascent stage at the moment, it is expanding at an almost exponential rate. With new players entering the market, increase in the number of collaborations and strong support from research institutes, the miRNA market is bound to witness rampant diversification and growth in the coming years.

Table of Contents

1. Analyst View

2. Research Methodology

3. miRNA - An Introduction

4. miRNA Techniques

  • 4.1. miRNA Purification
  • 4.2. miRNA Labeling
  • 4.3. miRNA Linear Amplification
  • 4.4. miRNA Microarrays
  • 4.5. miRNA qRT-PCR
  • 4.6. miRNA Inhibition

5. Global miRNA Market Outlook to 2018

  • 5.1. By Geography
    • 5.1.1. The Americas
    • 5.1.2. Europe
    • 5.1.3. Asia Pacific (APAC)

6. Ongoing miRNA Research by Disease

  • 6.1. Cancer
  • 6.2. Cardiovascular Diseases
  • 6.3. Metabolic Diseases
  • 6.4. Asthma
  • 6.5. Hepatitis

7. Key Players

  • 7.1. Mirna Therapeutics, Inc.
  • 7.2. Rosetta Genomics, Ltd.
  • 7.3. InteRNA Technologies B.V.
  • 7.4. Santaris Pharma A/S
  • 7.5. Regulus Therapeutics
  • 7.6. miRagen Therapeutics
  • 7.7. Qiagen
  • 7.8. Sigma-Aldrich Corporation
  • 7.9. Thermo Fisher Scientific Inc.
  • 7.10. Agilent Technologies Inc.
  • 7.11. Life Technologies Corporation
  • 7.12. System Biosciences
  • 7.13. GeneCopoeia

List of Figures:

  • Figure 3-1: miRNA Biogenesis
  • Figure 5-1: Global - miRNA Market (Million US$), 2012-2018
  • Figure 5-2: Ongoing miRNA Research by Geography (%), 2013
  • Figure 5-3: The Americas - miRNA Market (Million US$), 2012-2018
  • Figure 5-4: The Americas - Ongoing miRNA Research by Disease (%), 2013
  • Figure 5-5: Europe - miRNA Market (Million US$), 2012-2018
  • Figure 5-6: Europe - Ongoing miRNA Research by Disease (%), 2013
  • Figure 5-7: Europe - Ongoing miRNA Research by Country (%), 2013
  • Figure 5-8: APAC - miRNA Market (Million US$), 2012-2018
  • Figure 5-9: APAC - Ongoing miRNA Research by Disease (%), 2013
  • Figure 5-10: APAC - Ongoing miRNA Research by Country (%), 2013
  • Figure 6-1: Ongoing miRNA Research by Disease (%), 2013
  • Figure 6-2: Cancer - Ongoing miRNA Research (%), 2013

List of Tables:

  • Table 4-1: miRNA Purification Products by Supplier
  • Table 4-2: miRNA Labeling Products by Supplier
  • Table 4-3: miRNA Linear Amplification Products by Supplier
  • Table 4-4: miRNA Microarray Products by Supplier
  • Table 4-5: miRNA qRT-PCR Products by Supplier
  • Table 4-6: miRNA Inhibition Products by Supplier
  • Table 5-1: The Americas - Ongoing miRNA Research (2013)
  • Table 5-2: Europe - Ongoing miRNA Research (2013)
  • Table 5-3: APAC - Ongoing miRNA Research (2013)
  • Table 6-1: miRNAs associated with Cancer
  • Table 6-2: miRNA associated with Cardiovascular Diseases
  • Table 6-3: miRNAs associated with Metabolic Disorders
  • Table 6-4: miRNAs associated with Hepatitis
  • Table 7-1: Mirna Therapeutics - miRNA Research Pipeline
  • Table 7-2: Rosetta Genomics - miRNA based Cancer Tests
  • Table 7-3: InteRNA - miRNA Research Pipeline
  • Table 7-4: Santaris Pharma - miRNA Research Pipeline
  • Table 7-5: Regulus Therapeutics - miRNA Research Pipeline
  • Table 7-6: miRagen - miRNA Research Pipeline
  • Table 7-7: Qiagen - miRNA Associated Product Line
  • Table 7-8: Sigma Aldrich - miRNA Associated Product Line
  • Table 7-9: Thermo Fisher - miRNA Associated Product Line
  • Table 7-10: Agilent - miRNA Associated Product Line
  • Table 7-11: Life Technology - miRNA Associated Product Line
  • Table 7-12: System Biosciences - miRNA Associated Product Line
  • Table 7-13: GeneCopoeia - miRNA Associated Product Line
Show More
Pricing
Get Notified
Email me when related reports are published